RSS - Valeant-IR News Releases https://ir.bauschhealth.com/news-releases en Valeant https://ir.bauschhealth.com/~/media/Images/V/Valeant-IR/logo/logo-rss.jpg <![CDATA[Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026]]> https://ir.bauschhealth.com/news-releases/2026/07-07-2026-123937612 Tue, 07 Jul 2026 12:00:00 GMT Tue, 07 Jul 2026 12:47:47 GMT {6A3CE47B-F683-4C50-A91C-82F1993C1657} False <![CDATA[Le Québec est la première province à inscrire <sup>Pr</sup>OKEDI<sup style="font-weight:normal;">MD</sup> (suspension injectable à libération prolongée de rispéridone) sur la liste des médicaments remboursés par le régime public pour le traitement de la schizophrénie]]> https://ir.bauschhealth.com/news-releases/2026/07-06-2026-fr Mon, 06 Jul 2026 12:00:00 GMT Mon, 06 Jul 2026 12:02:15 GMT {A80A31D1-3B05-4CCB-A31D-A390FB810697} True <![CDATA[Québec is the first province to list <sup style="font-weight:normal;">Pr</sup>OKEDI<sup style="font-weight:normal;">MC</sup> (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of schizophrenia]]> https://ir.bauschhealth.com/news-releases/2026/07-06-2026-en Mon, 06 Jul 2026 12:00:00 GMT Mon, 06 Jul 2026 12:02:05 GMT {802BE7EC-8EEB-4851-838A-79DF77E0192F} True <![CDATA[Michael Goettler Resigns from Bausch Health's Board of Directors]]> https://ir.bauschhealth.com/news-releases/2026/07-01-2026-211607726 Wed, 01 Jul 2026 21:15:00 GMT Wed, 01 Jul 2026 21:17:48 GMT {A531B1A5-40FA-43DF-8892-DD36E6CA8501} True <![CDATA[Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of <sup style="font-weight:normal;">Pr</sup>OKEDI<sup style="font-weight:normal;">®</sup> (Risperidone for extended-release injectable suspension) for the treatment of schizophrenia]]> https://ir.bauschhealth.com/news-releases/2026/06-09-2026-en Tue, 09 Jun 2026 13:55:07 GMT Tue, 09 Jun 2026 17:41:27 GMT {2F9C62DD-CECE-436A-8FFB-5EC0D1667671} True <![CDATA[Bausch Health, Canada Inc. et l’Alliance pancanadienne pharmaceutique concluent avec succès leurs négociations, menant à la signature d’une lettre d’intention pour OKEDI<sup style="font-weight:normal;">MC</sup> (suspension injectable à libération prolongée de rispéridone) dans le traitement de la schizophrénie]]> https://ir.bauschhealth.com/news-releases/2026/06-09-2026-fr Tue, 09 Jun 2026 13:55:07 GMT Tue, 09 Jun 2026 17:42:09 GMT {BDBC9BBE-3DF1-49B6-B5E3-0BE530B14FA7} True <![CDATA[Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China]]> https://ir.bauschhealth.com/news-releases/2026/05-28-2026-211556273 Thu, 28 May 2026 21:15:00 GMT Thu, 28 May 2026 21:17:26 GMT {DBBA9BEA-586A-4F9A-91AC-EE7C40BB920A} True <![CDATA[Bausch Health Announces 2026 Annual Meeting of Shareholder Results]]> https://ir.bauschhealth.com/news-releases/2026/05-19-2026-211533403 Tue, 19 May 2026 21:15:00 GMT Tue, 19 May 2026 21:17:00 GMT {57C39AA2-1354-4738-BD86-2CEB845BF584} False <![CDATA[Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference]]> https://ir.bauschhealth.com/news-releases/2026/05-13-2026-120129805 Wed, 13 May 2026 12:00:00 GMT Wed, 13 May 2026 12:13:55 GMT {773F8CE4-96F6-48FF-98EF-2CCA64AAE517} False <![CDATA[Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference]]> https://ir.bauschhealth.com/news-releases/2026/05-12-2026-211559374 Tue, 12 May 2026 21:15:00 GMT Tue, 12 May 2026 21:51:21 GMT {B83795DD-7B20-41E9-A75A-2ED540CDEC19} False